Epirubicin chemotherapy in women with breast cancer: Alternating arms for intravenous administration to reduce chemical phlebitis
Author:
Affiliation:
1. Velindre Cancer Centre Cardiff UK
2. Faculty of Life Sciences and Education University of South Wales Pontypridd UK
Funder
Velindre Cancer Centre Charitable funds
Publisher
Wiley
Subject
Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ecc.13114
Reference29 articles.
1. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer
2. Effective prevention of 5-fluorouracil–induced superficial phlebitis by ketoprofen lysine salt gel
3. Epirubicin for breast cancer may cause considerable venous sclerosis
4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
5. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): A multicentre, phase 3, open‐label, randomised, controlled trial;Cameron D.;The Lancet Oncology,2017
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mesenchymal Stem Cells Target Gastric Cancer and Deliver Epirubicin via Tunneling Nanotubes for Enhanced Chemotherapy;Current Stem Cell Research & Therapy;2024-11
2. Phlebitis: a threat to patient safety in hospital care;European Journal of Cardiovascular Nursing;2024-05-08
3. Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review;Critical Reviews in Oncology/Hematology;2024-04
4. Composition, preparation methods, and applications of nanoniosomes as codelivery systems: a review of emerging therapies with emphasis on cancer;Nanoscale;2024
5. Chemotherapy induced phlebitis experienced by women with breast cancer following administration of epirubicin using a volumetric infusion pump: an observational study;European Journal of Oncology Nursing;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3